Cargando…
S100A7-Downregulation Inhibits Epidermal Growth Factor-Induced Signaling in Breast Cancer Cells and Blocks Osteoclast Formation
S100A7 is a small calcium binding protein, which has been shown to be differentially expressed in psoriatic skin lesions, as well as in squamous cell tumors of the skin, lung and breast. Although its expression has been correlated to HER+ high-grade tumors and to a high risk of progression, the mole...
Autores principales: | Paruchuri, Vikram, Prasad, Anil, McHugh, Kevin, Bhat, Hari K., Polyak, Kornelia, Ganju, Ramesh K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254193/ https://www.ncbi.nlm.nih.gov/pubmed/18320059 http://dx.doi.org/10.1371/journal.pone.0001741 |
Ejemplares similares
-
Phytoestrogens and Breast Cancer Prevention: Possible Mechanisms of Action
por: Mense, Sarah M., et al.
Publicado: (2008) -
Abstract 100: Osteoclast Activity Required For Cranial Suture Patency
por: Topczewska, Jolanta M., et al.
Publicado: (2018) -
The Expression of Psoriasin (S100A7) and CD24 Is Linked and Related to the Differentiation of Mammary Epithelial Cells
por: Vegfors, Jenny, et al.
Publicado: (2012) -
Sclerostin expression in trabecular bone is downregulated by osteoclasts
por: Koide, Masanori, et al.
Publicado: (2020) -
miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer
por: Zhao, Helong, et al.
Publicado: (2015)